GHK-Cu
Explore GHK-Cu, including its naturally occurring role in copper binding, published skin and tissue research, current compounding considerations, and available product pathways.
What Is GHK-Cu?
GHK-Cu is a naturally occurring complex formed when the tripeptide glycyl-L-histidyl-L-lysine binds copper. It has been identified in human plasma and other body fluids and has been studied for its role in copper transport and tissue-remodeling signals.
Published research has examined GHK-Cu in skin biology, collagen and extracellular-matrix activity, wound models, inflammation, and hair-related applications. Much of the evidence comes from laboratory, animal, or small clinical studies, so findings should not be treated as proof of broad clinical benefit.
GHK-Cu is not an FDA-approved drug. Cosmetic copper-peptide products and patient-specific compounded prescriptions are distinct pathways with different regulatory and clinical considerations.
What Has GHK-Cu Been Studied For?
Researchers have studied GHK-Cu in relation to skin appearance, collagen and elastin production, extracellular-matrix remodeling, wound-healing biology, antioxidant and inflammatory pathways, and hair-follicle activity.
The strongest body of published work is mechanistic and preclinical. Reviews note that copper peptides are widely used in cosmetic products, while standardized human clinical evidence remains limited. Product claims should therefore be evaluated in light of the specific formulation, route of use, and available evidence.
Laboratory or animal findings do not establish that the same results will occur in people, and GHK-Cu should not be presented as a treatment for a disease or injury without appropriate clinical evidence.
GHK-Cu: Current Regulatory & Compounding Status
GHK-Cu is not an FDA-approved drug. FDA currently identifies injectable GHK-Cu among bulk substances that may present significant safety risks, citing potential immunogenicity from aggregation or peptide-related impurities and limited human safety data.
FDA's treatment of non-injectable GHK-Cu under the 503A bulks evaluation process is separate and can change as the agency reviews nominations and evidence. Eligibility for compounding depends on current law, route of administration, clinical need, and the circumstances of an individual prescription.
Commercially manufactured topical copper-peptide products are not the same as compounded prescription drugs. Freedom can help patients and prescribers understand the currently available pathways without implying that an unapproved product has been reviewed by FDA for safety or effectiveness.
GHK-Cu Products & Prescription Pathways
-
Topical Copper-Peptide Products
Explore Copper-Peptide ProductsExplore commercially manufactured topical products featuring copper peptides. Product ingredients, concentrations, and directions vary, so review each label carefully.
-
Prescription Compounding Questions
Ask About GHK-CuFreedom's pharmacists can discuss whether a current, lawful patient-specific compounding pathway may be appropriate for a prescriber's identified clinical need.
GHK-Cu Frequently Asked Questions
Is GHK-Cu FDA approved?
No. GHK-Cu is not an FDA-approved drug. Cosmetic products containing copper peptides are also not FDA-approved treatments for disease.
Can GHK-Cu be compounded?
Compounding eligibility depends on current federal and state requirements, the route of administration, and a patient-specific prescription. FDA has specifically identified injectable GHK-Cu as presenting potential significant safety risks. Contact Freedom for current availability.
Does Freedom offer GHK-Cu product pathways?
Freedom can help patients and prescribers review currently available topical product and prescription pathways. Availability and eligibility may change, so confirm current options directly with the pharmacy.
What has GHK-Cu been studied for?
Research has examined skin and extracellular-matrix biology, collagen-related signaling, wound models, inflammation, and hair-follicle activity. Much of this evidence is laboratory or preclinical.
Is there human research on GHK-Cu?
Some human and cosmetic-use research has been published, but reviews continue to note limited standardized clinical evidence. Results from a specific formulation should not be generalized to every GHK-Cu product.
Are topical copper-peptide products the same as compounded GHK-Cu?
No. Commercial cosmetic products and compounded prescription drugs differ in intended use, formulation, oversight, and labeling. They should be evaluated separately.
Does Freedom sell research-use-only GHK-Cu?
No. Freedom Compounding Pharmacy serves patients and licensed healthcare providers and does not sell research-use-only peptides.
Questions About GHK-Cu?
Freedom Compounding Pharmacy can help patients and healthcare providers understand GHK-Cu research, current regulatory considerations, and the distinction between topical products and prescription compounding.